Comparison of the (pro)convulsive properties of fluvoxamine and clovoxamine with eight other antidepressants in an animal model.
Freely moving rats were implanted with cortical, caudal, thalamic, and reticular electrodes. Drugs were infused intravenously at a constant rate up to a final cumulative dose of 40, 50, or 60 mg/kg. Doses of 10 mg/kg imipramine, viloxazine, desmethylimipramine, mianserin, and maprotiline produced spike-wave complexes, spikes, and increased spindling. General sustained discharges occurred after 20 mg/kg of mianserin, viloxazine, imipramine, desmethylimipramine and amitriptyline, and after 30 mg/kg of maprotiline. An abnormal high-amplitude pattern was evident after mianserin, amitriptyline, imipramine, and desmethylimipramine. On the average, seizures were observed at 40 mg/kg and were seen after desmethylimipramine (50 mg/kg), mianserin (30 mg/kg), amitriptyline (20 mg/kg), imipramine (40 mg/kg), maprotiline (40 mg/kg), and zimelidine (50 mg/kg). Ranking the tested antidepressants in decreasing order in accordance with their relative (pro)convulsive properties gives: amitriptyline greater than mianserin much greater than imipramine greater than desmethylimipramine greater than viloxazine much greater than maprotiline much greater than zimelidine greater than clovoxamine greater than nomifensine = fluvoxamine.
D000639:Amitriptyline / Q000009:adverse effects; D000818:Animals; D000928:Antidepressive Agents / Q000009:adverse effects*; D003891:Desipramine / Q000009:adverse effects; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004569:Electroencephalography; D004827:Epilepsy / Q000139:chemically induced; D016666:Fluvoxamine; D007099:Imipramine / Q000009:adverse effects; D008297:Male; D008376:Maprotiline / Q000009:adverse effects; D008803:Mianserin / Q000009:adverse effects; D010091:Oximes / Q000009:adverse effects*; D051381:Rats; D011919:Rats, Inbred Strains; D012640:Seizures / Q000139:chemically induced*; D014745:Viloxazine / Q000009:adverse effects
D000928:Antidepressive Agents; D010091:Oximes; D000639:Amitriptyline; D008803:Mianserin; D008376:Maprotiline; D014745:Viloxazine; C020724:clovoxamine; D016666:Fluvoxamine; D007099:Imipramine; D003891:Desipramine